University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 2N-06-8


 
Description: A Multi-Center, Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Cancer Vaccine Stimuvax (L-BLP25 or BLP25 Liposome Vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects with Unresectable Stage III Disease.
Status: Open
Randomized? Yes


Researchers  
Principal InvestigatorTitle
Barbara GitlitzM.D.

Data Management
NameTitle
Charlean KetchensR.N.
Lagrimas IlaganD.M.
Vatche StepanianD.M.
Gina TseR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.